Mortality in patients with left ventricular ejection fraction </=30% after primary percutaneous coronary intervention
Jan Paul Ottervanger1, Anand R Ramdat Misier, Jan-Henk E Dambrink
1Department of Cardiology, Isala klinieken, Zwolle, The Netherlands. v.r.c.derks@isala.nl
Insights
Patients with reduced left ventricular (LV) function after heart attack and primary percutaneous coronary intervention have better survival than previously thought. This suggests a need to re-evaluate the routine use of implantable cardioverter-defibrillators (ICDs) in this population.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Decreased left ventricular (LV) function is a significant predictor of mortality following myocardial infarction.
- Current guidelines suggest prophylactic implantable cardioverter-defibrillator (ICD) implantation for patients with ST-elevation myocardial infarction and LV ejection fraction ≤30% after one month.
- Improved reperfusion therapies and increased use of life-saving medications may alter the prognosis of these patients compared to historical ICD trials.
Purpose of the Study:
- To prospectively assess the 1-year mortality rate in patients with depressed LV ejection fractions after primary percutaneous coronary intervention (PCI).
- To compare current outcomes with historical data from randomized trials of ICDs in similar patient populations.
Main Methods:
- A prospective, observational study was conducted.
- Data were collected from patients who survived at least 30 days after primary PCI and had an LV ejection fraction (LVEF) of ≤30% between 1994 and 2004.
- One-year mortality and causes of death were analyzed.
Main Results:
- Out of 2,544 patients, 342 (13%) had an LVEF ≤30%.
- The 1-year mortality rate in this cohort was 5.8%.
- Sudden death was the most frequent cause of mortality (40%), often associated with multivessel disease and recurrent myocardial infarction within the first year.
Conclusions:
- One-year mortality for patients with depressed LV function after primary PCI is lower than previously reported in major ICD trials.
- The findings suggest that the benefits of prophylactic ICD therapy in this specific patient group warrant further investigation and re-evaluation.
- Improved contemporary medical and interventional management may be contributing to better outcomes.
Abstract:
Decreased left ventricular (LV) function is a strong predictor of mortality. Although current guidelines recommend prophylactic implantable cardioverter-defibrillator (ICD) implantation after ST-elevation myocardial infarction and a depressed LV ejection fraction for 1 month, the prognoses of these patients may be better than those observed in randomized trials of ICDs (1-year mortality 6.8% to 19%), particularly because reperfusion treatment has improved, and the use of life-saving drugs is higher. To assess 1-year mortality in patients with depressed LV ejection fractions after primary percutaneous coronary intervention, a prospective, observational study was performed. Data from all patients who survived >/=30 days after primary percutaneous coronary intervention and had LV ejection fractions =30% from 1994 to 2004 were recorded. Of 2,544 patients, 342 (13%) had LV ejection fractions =30%. One-year mortality was 5.8%. Sudden death was the most common cause of death (40%). Patients who died more often had multivessel disease and a higher incidence of recurrent myocardial infarction within 1 year. In conclusion, current mortality in patients with depressed LV ejection fractions after primary percutaneous coronary intervention is much better than that observed in previous ICD trials, and the benefits of ICD therapy in these patients should be further evaluated.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
